These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29615345)

  • 1. Synthesis, biological evaluation, and molecular docking investigation of benzhydrol- and indole-based dual PPAR-γ/FFAR1 agonists.
    Darwish KM; Salama I; Mostafa S; Gomaa MS; Khafagy ES; Helal MA
    Bioorg Med Chem Lett; 2018 May; 28(9):1595-1602. PubMed ID: 29615345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
    Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
    Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology modeling and explicit membrane molecular dynamics simulation to delineate the mode of binding of thiazolidinediones into FFAR1 and the mechanism of receptor activation.
    Helal MA; Darwish KM; Hammad MA
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5330-6. PubMed ID: 25441945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ.
    Li Z; Zhou Z; Deng F; Li Y; Zhang D; Zhang L
    Eur J Med Chem; 2018 Nov; 159():267-276. PubMed ID: 30296685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity.
    Piemontese L; Cerchia C; Laghezza A; Ziccardi P; Sblano S; Tortorella P; Iacobazzi V; Infantino V; Convertini P; Dal Piaz F; Lupo A; Colantuoni V; Lavecchia A; Loiodice F
    Eur J Med Chem; 2017 Feb; 127():379-397. PubMed ID: 28076827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach.
    Gim HJ; Choi YS; Li H; Kim YJ; Ryu JH; Jeon R
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists.
    Dropinski JF; Akiyama T; Einstein M; Habulihaz B; Doebber T; Berger JP; Meinke PT; Shi GQ
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5035-8. PubMed ID: 16153845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of alkoxyindolyl-3-acetic acid analogs as peroxisome proliferator-activated receptor-γ/δ agonists.
    Gim HJ; Li H; Lee E; Ryu JH; Jeon R
    Bioorg Med Chem Lett; 2013 Jan; 23(2):513-7. PubMed ID: 23265886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors -α/γ dual agonists for treatment of metabolic disorders.
    Nath V; Agrawal R; Kumar V
    J Biomol Struct Dyn; 2020 Feb; 38(2):511-523. PubMed ID: 30767625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new dual PPARγ-GPR40 agonists with robust antidiabetic activity: Design, synthesis and in combo drug evaluation.
    Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S; Giles-Rivas D; Alarcón-Aguilar FJ; León-Rivera I; Giacoman-Martínez A; Miranda Pérez E; Almanza-Pérez JC
    Biomed Pharmacother; 2017 Jun; 90():53-61. PubMed ID: 28342366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K
    Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study.
    Chiellini G; Nesi G; Sestito S; Chiarugi S; Runfola M; Espinoza S; Sabatini M; Bellusci L; Laurino A; Cichero E; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
    J Med Chem; 2016 Nov; 59(21):9825-9836. PubMed ID: 27731647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.
    Ibrahim MK; Eissa IH; Alesawy MS; Metwaly AM; Radwan MM; ElSohly MA
    Bioorg Med Chem; 2017 Sep; 25(17):4723-4744. PubMed ID: 28720328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of benzoxazole containing indole analogs as peroxisome proliferator-activated receptor-γ/δ dual agonists.
    Gim HJ; Cheon YJ; Ryu JH; Jeon R
    Bioorg Med Chem Lett; 2011 May; 21(10):3057-61. PubMed ID: 21482466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists.
    Mahindroo N; Peng YH; Lin CH; Tan UK; Prakash E; Lien TW; Lu IL; Lee HJ; Hsu JT; Chen X; Liao CC; Lyu PC; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2006 Oct; 49(21):6421-4. PubMed ID: 17034149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists.
    Kuhn B; Hilpert H; Benz J; Binggeli A; Grether U; Humm R; Märki HP; Meyer M; Mohr P
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4016-20. PubMed ID: 16737814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILD.
    Bhurruth-Alcor Y; Røst T; Jorgensen MR; Kontogiorgis C; Skorve J; Cooper RG; Sheridan JM; Hamilton WD; Heal JR; Berge RK; Miller AD
    Org Biomol Chem; 2011 Feb; 9(4):1169-88. PubMed ID: 21157612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G
    Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists.
    Peng YH; Coumar MS; Leou JS; Wu JS; Shiao HY; Lin CH; Lin WH; Lien TW; Chen X; Hsu JT; Chao YS; Huang CF; Lyu PC; Hsieh HP; Wu SY
    ChemMedChem; 2010 Oct; 5(10):1707-16. PubMed ID: 20734309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.